SJÖGREN'S SYNDROME: TREATMENT OF COMPLICATIONS AND IMPROVEMENTS IN GLANDULAR FUNCTION

Authors

  • Raíssa Vasconcelos Bittencourt Boaventura Médica pela Universidade Evangélica de Goiás - UniEVANGÉLICA
  • Maria Carolina Fagundes Rodrigues Médica pela UnB
  • Denise Coelho de Almeida Médica pelo Uninovafapi
  • Jemima Silva Kretli médica pelo UNINOVAFAPI
  • Evelise Almeida Viana Médica pela Faculdade de Medicina de Barbacena/Fame
  • Raimundo Franklin de Oliveira Neto Médico pela UNINOVAFAPI.
  • Sérgio Henrique Assunção Lacerda Borges Médico pela UNINOVAFAPI
  • Alícia Cunha de Freitas médica pelo UNINOVAFAPI
  • Heitor Motta Bini Pereira Médico pela FCMS/JF dermatologista pela PGRJ
  • Darlan Lopes Fernandes Médico pela Universidad Privada Maria Serrana
  • Janderson de Castro e Silva Médico pela Universidade Federal de Roraima (UFRR)
  • Luiza Maria Barbosa Maranhão Médica pelo Centro Universitário de João Pessoa
  • Gabriel Braz de Carvalho Ferreira Estudante de Medicina pela Universidade Federal de Juiz de Fora (UFJF)
  • Wytória Christian Justino Pereira Estudante de Medicina da Universidade Federal de Juiz de Fora (UFJF)

DOI:

https://doi.org/10.36557/2674-8169.2024v6n7p2881-2895

Keywords:

Sjögren's Syndrome, Treatment, Glandular Function.

Abstract

Sjögren's Syndrome is an autoimmune disease that mainly affects the glands that produce saliva and tears, causing significant dryness in the mouth and eyes.  Thus, an integrated approach that combines pharmacological and non-pharmacological strategies, adapted to individual needs, has shown effectiveness in reducing symptoms and generally improving the quality of life of patients with this syndrome. Objective: To identify the pathophysiological mechanisms underlying the syndrome and evaluate the effectiveness of different therapeutic interventions to control symptoms and prevent complications. Methodology: The Cochrane, Scielo and Medline databases were used, searching for articles published between 2016 and 2024, in Portuguese or English. Final Considerations: The therapeutic approach to Sjögren's Syndrome is diverse and essential for patients' quality of life. Firstly, interventions include immunosuppressive agents. Additionally, tear and saliva substitutes are important to alleviate dryness symptoms. Procedures such as occlusion of tear punctums and glandular electrical stimulation, as well as nutritional supplementation and oral and eye care, are also essential. Therefore, the combination of pharmacological and non-pharmacological strategies, personalized for each patient, is effective in reducing symptoms and improving quality of life.

Downloads

Download data is not yet available.

References

CAPACCIO, P. et al. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren’s syndrome: Results of a pilot monocentric trial. Clinical Otolaryngology, v. 43, n. 1, p. 96–102, 26 jun. 2017.

DE WOLFF, L. et al. Long-term abatacept treatment for 48 weeks in patients with primary Sjögren’s syndrome: The open-label extension phase of the ASAP-III trial. Seminars in Arthritis and Rheumatism, v. 53, p. 151955, 1 abr. 2022.

DU, H. et al. A randomized controlled trial to verify the irrigation of salivary glands in relieving xerostomia in patients with Sjögren’s syndrome. Frontiers in Immunology, v. 13, p. 1039599, 2022.

FELBERG, S.; DANTAS, P. E. C.; SATO, E. H. Pilocarpina oral no tratamento do olho seco de pacientes com síndrome de Sjögren. Arquivos Brasileiros de Oftalmologia, v. 85, n. 3, 2022.

JAGER, D. et al. Sialendoscopy of Salivary Glands Affected by Sjögren Syndrome: A Randomized Controlled Pilot Study. Journal of Oral and Maxillofacial Surgery, v. 74, n. 6, p. 1167–1174, 1 jun. 2016.

MARTÍN, L. L. et al. Sterile, recurrent, and bilateral corneal perforation related to primary biliary cirrhosis complicated by secondary Sjögren syndrome and vitamin A deficiency. Arquivos Brasileiros de Oftalmologia, v. 84, p. 606–609, 18 ago. 2021.

PASCOTO, G. R. et al. Sialendoscopy for Improvement of Salivary Flow in Patients with Sjögren Syndrome - Comparative Analysis of Intraglandular Washing Solutions. International Archives of Otorhinolaryngology, v. 25, n. 01, p. e6–e11, 30 set. 2020.

SALEEM, R. A. et al. Laboratory features and pharmacological management of early and late-onset primary Sjögren’s syndrome. Rheumatol Int, p. 1317–1325, 2024.

VARGAS, J. F. DA C. et al. Subconjunctival adalimumab for treatment of dry eye disease in Sjögren’s syndrome. Revista Brasileira de Oftalmologia, v. 81, 2022.

YANG, Z. et al. Clinical features and risk factors for primary Sjögren’s syndrome combined with interstitial lung disease: a retrospective study. Acta Biochim Pol, p. 12461–12461, 2024.

Downloads

Published

2024-07-28

How to Cite

Boaventura, R. V. B., Rodrigues, M. C. F., Almeida, D. C. de, Kretli, J. S., Viana, E. A., Neto, R. F. de O., Borges, S. H. A. L., Freitas, A. C. de, Pereira, H. M. B., Fernandes, D. L., Silva, J. de C. e, Maranhão, L. M. B., Ferreira, G. B. de C., & Pereira , W. C. J. (2024). SJÖGREN’S SYNDROME: TREATMENT OF COMPLICATIONS AND IMPROVEMENTS IN GLANDULAR FUNCTION. Brazilian Journal of Implantology and Health Sciences, 6(7), 2881–2895. https://doi.org/10.36557/2674-8169.2024v6n7p2881-2895

Issue

Vol. 6 No. 7 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807

Section

Literature Review

License

Copyright (c) 2024 Raíssa Vasconcelos Bittencourt Boaventura, Maria Carolina Fagundes Rodrigues, Denise Coelho de Almeida, Jemima Silva Kretli, Evelise Almeida Viana, Raimundo Franklin de Oliveira Neto, Sérgio Henrique Assunção Lacerda Borges, Alícia Cunha de Freitas, Heitor Motta Bini Pereira, Darlan Lopes Fernandes, Janderson de Castro e Silva, Luiza Maria Barbosa Maranhão, Gabriel Braz de Carvalho Ferreira, Wytória Christian Justino Pereira

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors are copyright holders under a CCBY 4.0 license.